“Pharmacological Evaluation of New 4, 5-dihydro-1H- Pyrazole-1-yl acetate Derivatives as anti-cancer agents” (2023) Al Mustansiriyah Journal of Pharmaceutical Sciences, 22(4), pp. 80–89. doi:10.32947/ajps.v22i4.963.